23:10:44United Kingdom

Skye Bioscience, Inc. (SKYE)

NASDAQ

Key stats Fiscal year 2025

Income statement

Net income
-55,924,814
Operating income
-58,163,565
Earnings per share
-1.41

Growth and profitability

Return on equity
-279.29
Return on assets
-197.52

Balance sheet

Total assets
28,313,633
Total liabilities
8,289,458
Shareholders' equity
20,024,175
Cash and equivalents
5,882,498
Current ratio
3.30

Cash flow and ratios

Operating cash flow
-43,062,529
Free cash flow
-43,068,841

Shareholder returns

Shares outstanding
4,423,469
Book value per share
4.53
Revenue and net income
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
San Diego, CA
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Skye Bioscience, Inc. trades on NASDAQ under the ticker symbol SKYE. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis